Abstract:Objective: To construct DNA vaccine (pIRES-Sj97-Sj14-Sj26) and study its immunogenicity and protective immunity against Schistosoma japonicum. Methods: The plasmid pIRES-Sj97-Sj14-Sj26 containing fatty binding protein (Sj14), GST (Sj26) and paramyosin (Sj97) was constructed and expressed on the membrane. RT-PCR was used to detect the expression of Sj14 mRNA, Sj26 mRNA and Sj97 mRNA in the Hela cells, and IFA for detecting the expression of trans-membrane Sj14, Sj26 and Sj97. Sixty BALB/c mice were randomly divided into 3 groups. Mice in each group respectively received normal saline, pIRES blank vector and pIRES-Sj97-Sj14-Sj26 by intramuscular injection. Two weeks after the 3rd immunization, 10 mice from each group were sacrificed and total IgG in serum and the level of IFN-y were detected by ELISA and lymphocyte stimulating index (SI) by MTt. FCM was used to analyze the subgroups of splenocytes. The level of NO secreted by peritoneal macrophages was determined by nitrate reductase approaches. The left 10 mice in each group were challenged with (40 +/- 1) cercariae of S. japonicum by abdominal skin penetration. Forty-five days after challenge, mice were sacrificed, and numbers of recovered worms and hepatic eggs were counted. Results: RT-PCR showed the expression of Sj14 mRNA, Sj26 mRNA and Sj97 mRNA. IFA proved the expression of Sj26, Sj14 and Sj97 protein. Level of total IgG in the vaccination group, saline group and pIRES blank vector group was (5.62 +/- 0.64), (1.22 +/- 0.20) and (1.48 +/- 0.36) mg/ml respectively, showing a statistical significance (P < 0.01, P < 0.05). The NO level in macrophages was (321.19 +/- 18.03), (184.12 +/- 11.05) and (213.51 +/- 15.93) nmol/ml in the 3 groups respectively (P < 0.05), and the lymphocyte stimulating index in the 3 groups was (2.25 +/- 0.29), (1.18 +/- 0.07) and(1.22 +/- 0.09) respectively (P < 0.01). The INF-gamma level was higher in the vaccination group than others (P < 0.01). The percentage of CD4+ and CD8+ T cells increased considerably (P < 0.01). The vaccination group showed a worm reduction rate of 39.9% (P < 0.01) and an egg reduction rate of 43.9% (P < 0.01). Conclusion: The vaccine candidate pIRES-Sj97-Sj14-Sj26 induces an immune protection in BALB/c mice against Schistosoma japonicum.

IMMUNOSCREENING OF SCHISTOSOMA JAPONICUM ADULT Cdna LIBRARY USING PROTECTIVE SERA AND MONOCLONE ANTIBODIES

Immune screening of Schistosoma japonicum cercaria cDNA library by sera from rabbits vaccinated with irradiated cercariae

[Screening of Schistosoma Japonicum Adult Worm Genomic DNA Library by Specific Antibody].

Screening of Schistosoma Japonicum Cercaria Cdna Library Using the Schistosoma Japonicum Natural Molecular Vaccine Induced Immune Sera

Immunoscreening and Identification of Schistosoma Japonicum Juvenile Cdna Library

Screening, Cloning and Immunological Efficiency of SjPP, a Novel Schistosoma Japonicum Gene

Immune Reactivity Between the Stage-Specific Antigenic Components from Schistosoma Japonicum and the Immune Sera from Rabbits Vaccinated with Irradiated Cercariae

[Immunoscreening of Schistosoma Japonicum Egg Cdna Library and Identification of Positive Clones].

PROTECTIVE IMMUNITY INDUCED BY A RECOMBINANT ANTIGEN RSJ06868 OF SCHIISTOSOMA JAPONICUM

[Cloning and Identification of an Unknown Gene Encoding 10.6 Kda Protein of Schistosoma Japonicum].

Identification and profiling of circulating antigens by screening with the sera from schistosomiasis japonica patients

Protective Effect Induced by Vaccination with a Partial cDNA Expression Library of Schistosoma japonicum in Mice

Cloning, expressing and functional analysis of SjMF4, a novel Schistosoma japonicum gene]

A candidate recombinant antigen for diagnosis of schistosomiasis japonica in domestic animals.

Cloning, Expression And Immunization Of The Hypoxanthine-Guanine Phosphoribosyltransferase For Schistosoma Japonicum Chinese Strain

[A multi-gene DNA vaccine encoding non-fusion membrane-anchoring antigen against Schistosoma japonicum]

Construction of a Novel Schistosoma Japonicum DNA Vaccine Pbk-Sj14-3-3 and Studies on Its Immunoprotection in Mice

[Cloning, Expression and Immunodiagnostic Analysis of Schistosoma Japonicum Calcium-Binding EF-hand Domain Containing Protein].

STUDIES ON THE IMMUNOACTIVITY OF THE ANTIGENIC MIMIC EPITOPES OF SCHISTOSOMA JAPONICUM

Novel Hepatic Schistosomula Antigens As Promising Targets for Immunodiagnosis and Immunoprotection of Schistosomiasis Japonica.

EXPRESSION ,PURIFICATION AND CHARACTERIZATION OF FABPc RECOMBINANT ANTIGEN OF SCHISTOSOMA JAPONICUM